Global X China Biotech ETF (HKG:2820)
64.50
-1.80 (-2.71%)
Mar 4, 2026, 3:55 PM HKT
HKG:2820 Holdings Information
HKG:2820 is an equity ETF with a total of 43 individual holdings. The top holdings are WuXi Biologics stock at 14.00%, Innovent Biologics at 12.28%, BeOne Medicines AG at 12.13%, WuXi AppTec at 9.45%, and Akeso at 8.58%.
Total Holdings
43
Top 10 Percentage
84.53%
Asset Class
Equity
ETF Category
Health Care
Assets
642.77M
PE Ratio
45.34
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 14.00% |
| 2 | HKG: 1801 | Innovent Biologics, Inc. | 12.28% |
| 3 | ONC | BeOne Medicines AG | 12.13% |
| 4 | SHA: 603259 | WuXi AppTec Co., Ltd. | 9.45% |
| 5 | HKG: 9926 | Akeso, Inc. | 8.58% |
| 6 | SHA: 600276 | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 8.43% |
| 7 | HKG: 1177 | Sino Biopharmaceutical Limited | 7.02% |
| 8 | HKG: 1530 | 3SBio Inc. | 5.03% |
| 9 | HKG: 3692 | Hansoh Pharmaceutical Group Company Limited | 4.96% |
| 10 | HKG: 2228 | XtalPi Holdings Limited | 2.64% |
| 11 | HKG: 0867 | China Medical System Holdings Limited | 2.05% |
| 12 | HKG: 6990 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2.02% |
| 13 | HKG: 1548 | Genscript Biotech Corporation | 1.58% |
| 14 | SHE: 300347 | Hangzhou Tigermed Consulting Co., Ltd | 1.23% |
| 15 | SHA: 688578 | Shanghai Allist Pharmaceuticals Co., Ltd. | 1.22% |
| 16 | SHE: 002252 | Shanghai RAAS Blood Products Co., Ltd. | 1.18% |
| 17 | SHE: 300255 | Hebei Changshan Biochemical Pharmaceutical Co., Ltd. | 1.18% |
| 18 | SHA: 603087 | Gan & Lee Pharmaceuticals. | 1.16% |
| 19 | HKG: 2617 | TransThera Sciences (Nanjing), Inc. | 1.00% |
| 20 | SHE: 300759 | Pharmaron Beijing Co., Ltd. | 0.96% |
| 21 | SHA: 688180 | Shanghai Junshi Biosciences Co., Ltd. | 0.63% |
| 22 | SHA: 600161 | Beijing Tiantan Biological Products Co., Ltd. | 0.58% |
| 23 | SHA: 688278 | Xiamen Amoytop Biotech Co., Ltd. | 0.46% |
| 24 | SHA: 688331 | RemeGen Co., Ltd. | 0.46% |
| 25 | SHE: 000513 | Livzon Pharmaceutical Group Inc. | 0.45% |
As of Mar 2, 2026